Definitive Contract FA304713C0009

Award Date 1/25/13
Potential Completion Date 1/31/18
Potential Value $294K
Funding Federal Agency
Air Force
Contracting Federal Agency
Air Education and Training Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Department of the Air Force Air Education and Training Command to Immucor Inc., a for-profit manufacturer, for the lease of blood typing analyzers with reagents. The contract has a total potential value of $117,340.43 and a completion date of September 30, 2019. This award is not associated with a set-aside program. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation...
Immucor Inc. has been awarded a $634,672.80 firm fixed price purchase order by the Department of the Air Force Air Education and Training Command to deliver a NEO IRIS Blood Analyzer by December 3, 2024. As a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing, Immucor will provide the specialized analyzer to support the medical testing programs of the Air Force. No set-aside designation was applied to this...
This is a $75,528.60 firm-fixed-price purchase order contract awarded by the U.S. Air Force's Air Combat Command to Immucor Inc., a for-profit manufacturer, on December 31, 2021. The contract is for the provision of blood bank reagents to support blood typing, compatibility testing, and other critical blood banking operations at Nellis Air Force Base in Nevada. It has a period of performance through September 30, 2025. The contract was set aside for small businesses. Immucor is an experienced...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This federal contract award to Immucor Inc. is for the provision of blood bank typing equipment to the U.S. Air Force's Air Education and Training Command (AETC). The contract has a ceiling value of $116,810.39 and a completion date of March 10, 2025. It is a firm fixed-price delivery order contract and does not have a set-aside designation. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
The Department of the Air Force Air Education and Training Command awarded a firm-fixed price delivery order contract worth $122,698.05 to Immucor Inc., a for-profit manufacturer of goods, for the provision of blood typing reagents. Immucor has extensive experience providing specialized reagents, blood analyzers, testing equipment, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood banking operations for federal health networks and...
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
This contract award to Immucor Inc. is for the delivery of in vitro diagnostic reagents, test kits, and associated equipment on a Firm Fixed Price basis. The contract is funded by the Defense Health Agency and the award has a potential value of $153,884.39. Immucor, a for-profit manufacturer, is providing these specialized medical supplies and services to support blood transfusion and transplantation compatibility testing programs for federal health networks and military treatment facilities....
This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract is for a base year plus four option years, with a ceiling value of $29,848.00, for the provision of blood bank reagents. The contract is issued under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and does not have a set-aside designation. Immucor is a key supplier of...

This is a definitive contract awarded by the U.S. Air Force to Immucor Inc., a leading provider of automated in vitro diagnostic equipment and consumables for blood transfusion and transplantation compatibility testing. The $294,151.80 firm fixed price contract is for the basic year lease of Immucor's NEO blood bank system, which supports critical blood banking operations within military medical facilities. Immucor has a history of federal contract awards to supply specialized reagents, analyzers, and test kits to enable blood typing, antibody screening, and other essential blood services for agencies including the Department of Veterans Affairs and the Defense Health Agency. This contract does not have a set-aside designation, and Immucor has provided these products and services both as a prime contractor and through its existing indefinite delivery contracts and GSA schedule agreements.

Generated 9/7/24, 11:40 AM